ChangeBridge: Patent Apps - Therapeutics (A61P)

Patent application for Dichrostachys glomerata health and wellness benefits

Patent application for Dichrostachys glomerata health and wellness benefits

Patent Application for Reducing Food Intake Using Plants

The USPTO has published a new patent application (US20260083800A1) detailing methods and compositions using Dichrostachys glomerata or Cissus quadrangularis to reduce food intake or appetite in mammals. The application was filed on September 26, 2024, by inventors Shil Kothari and Julius Enyoug Oben.

Patent Application for Reducing Visceral Fat Using Plants

The USPTO has published a new patent application (US20260083801A1) detailing methods and compositions for reducing visceral fat in mammals using plants like Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.

Patent Application: Methods for Reducing Blood Lipids Using Plants and Spices

The USPTO has published a new patent application (US20260083802A1) detailing methods and compositions for reducing blood lipids using plants and spices, specifically Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024.

Patent Application for Reducing Blood Glucose with Plants

The USPTO has published a new patent application (US20260083803A1) detailing methods and compositions for reducing fasting blood glucose in mammals using plants like Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.

Patent Application: Reducing DPP-4 Activity Using Plants

The USPTO has published a new patent application (US20260083804A1) detailing methods and compositions for reducing DPP-4 activity using plants like Dichrostachys glomerata or Cissus quadrangularis. The application, filed on September 26, 2024, aims to provide health benefits such as increased GLP-1 levels and reduced visceral fat.

Phytogenic Composition for Animal Skeletal Muscle Growth

The USPTO has published a patent application (US20260083805A1) detailing a phytogenic composition comprising Glycyrrhiza uralensis extract for promoting skeletal muscle growth in animals. This application outlines its use as a feed additive for agricultural applications.

USPTO Patent Application for Anti-CD38 Antibodies

The USPTO has published a patent application (US20260078199A1) for anti-CD38 antibodies, therapeutics, and diagnostics. The application, filed on July 14, 2025, details methods for treating autoimmune diseases and diagnostic assays.

USPTO Patent Application: Systems for Targeting Cancer Cells

The USPTO has published a new patent application, US20260078200A1, detailing systems and methods for targeting cancer cells using genetically modified immune cells. The application describes novel polypeptides and their use in killing target cancer cells.

Anti-PTK7 Antibody Patent Application

The USPTO has published a patent application (US20260078201A1) for an anti-PTK7 antibody. The antibody is described as inhibiting angiogenesis, tumor growth, and cancer, with potential therapeutic applications for angiogenesis-related diseases and PTK7-positive cancers.